Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
Guiqi Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Pei‐Yun Zhou(Fudan University), Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Zhi Dai(Ministry of Education of the People's Republic of China), Chenyang Tao(Ministry of Education of the People's Republic of China), Jun Gao(Nanchang University), Han Wang(Ministry of Education of the People's Republic of China), Jia Fan(Nanjing Tech University), Jian Zhou(Ministry of Education of the People's Republic of China), Zheng Tang(Ministry of Education of the People's Republic of China), Weiren Liu(Fudan University), Run Huang(Ministry of Education of the People's Republic of China), Haixiang Sun(Harbin Institute of Technology), Yuan Fang(Guangzhou University of Chinese Medicine), Shushu Song(Fudan University), Zhen‐Bin Ding(Fudan University), Xi‐Fei Jiang(Sun Yat-sen University), Yuan‐Fei Peng(Fudan University)
Cited by 44
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828